Globe and Mail Bausch & Lomb eye care products on display at Maximart Pharmacy in Palo Alto, Calif., on May 16, 2007. Valeant Pharmaceuticals Inc. has confirmed it's buying Bausch + Lomb Holdings in a US$8.7-billion cash deal that will boost the Canadian drug maker's ... and more »
CBC.ca "What we really see here is a fairly innovative way to address patient need and certainly a lot of people are self-diagnosing anyway, and they're not doing that with the benefit of a health provider," she said. Martin said Saskatchewan pharmacists have ...
CNN International The patent system was created more than two centuries ago with a dual purpose: offering temporary financial incentives for those at the ground floor of innovative products and ensuring that one company does not hold a lifetime monopoly that might ... and more »
Toronto Star Brent Saunders, the chief executive of Bausch + Lomb, said the companies share a commitment to providing innovative , high-quality products and service. “I...
